Table 2 Patient and tumor characteristics

From: Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas

 

Type I

Type II

P-value

No. of patients

108 (72.5%)

41 (27.5%)

 

Age (mean±s.d.)

61.0±11.0

67.4±12.5

0.00

Race

   

 Caucasian

76 (70%)

22 (54%)

0.054

 African-American

32 (30%)

19 (46%)

 

Stage a

   

 I

84 (78%)

17 (44%)

<0.001

 II

8 (7%)

5 (13%)

 

 III

12 (11%)

14 (33%)

 

 IV

1 (1%)

5 (10%)

 

 No data available

3 (3%)

0

 

Outcome

   

 Alive

83 (77%)

20 (49%)

0.001

 Dead

24 (22%)

21 (51%)

 

 No data available

1 (1%)

0

 

Histologic grade (FIGO)

   

 1

42 (39%)

N/A

 

 2

47 (43.5%)

  

 3

19 (17.5%)

  

Depth of invasion

   

 None

31 (29%)

8 (7%)

0.047

 Inner

42 (39%)

15 (33%)

 

 Outer

28 (26%)

18 (60%)

 

 No data available

7 (6%)

0

 

Vascular invasion

   

 Yes

41 (39%)

25 (61%)

0.015

 No

64 (59%)

15 (37%)

 

 No data available

3 (2%)

1 (2%)

 

Adnexal invasion

   

 Yes

9 (8%)

13 (31%)

0.002

 No

96 (89%)

28 (69%)

 

 No data available

3 (3%)

0

 
  1. aFIGO clinical stage.